S
everal aspects of cardiovascular physiology and the incidence of cardiovascular events, such as sudden cardiac death, myocardial infarction, unstable angina, ventricular tachycardia, and ischemic and hemorrhagic stroke, are subject to diurnal variation, peaking in the early morning hours. 1, 2 The early morning surge in blood pressure, accompanied by a decline in endothelial function, coincides with the peak incidence in clinical cardiovascular events. 3, 4 The corresponding oscillations in gene and protein expression of known regulators of vascular physiology highlight the potential importance of the vascular clock in the described diurnal variation of the incidence of cardiovascular events. 5, 6 Blood vessels are composed of 3 major layers. The inner layer is composed of a monolayer of endothelial cells that forms a barrier between the artery wall and the circulating blood. Endothelial cells determine blood-tissue permeability, control vascular tone, and regulate the properties of the vascular surface with regard to hemostasis. Endothelial cells release NO, which activates an enzymatic cascade in the smooth muscle cell (SMC) that results in smooth muscle relaxation and reduced vascular tone. Other molecules produced by the endothelial cells, such as endothelin-1 and angiotensin-II, act to contract SMCs. The endothelial surface contains a set of factors that regulate platelet adhesion, coagulation (thrombomodulin), and fibrinolysis (plasminogen activators, inhibitors). The medium layer of the blood vessel consists mainly of SMCs, which are responsible for vasoconstriction and vasodilation. Endothelial cells, circulating mediators and the sympathetic nervous system, regulate smooth muscle tone. Finally, the outer layer is a connective tissue structure that fuses the vessel with connective tissue from the surrounding organs. The outer layer contains fibroblasts, which, together with endothelial cells, plays a critical a role during the angiogenic process.
The oscillator exists as a self-sustained transcriptionaltranslational circuit consisting of positive and negative loops. This circuit creates a rhythm in gene expression with a period of approximately (circa-) 1 day (dies), which drives circadian rhythms and adapts the physiology of an organism to its needs in an anticipatory manner. The organization of physiology appropriately to adapt to changes in the timing of recurring events (eg, sunrise, the time of food availability) lies in the ability of the circadian oscillator to synchronize its phase in response to external cues. Importantly, the increased frequency of disorders such as obesity and the metabolic syndrome among night-shift workers and those with sleeping disorders suggests broader involvement of the circadian clock in chronic disorders of physiology. 7 The molecular core of the circadian clock consists of a negative feedback loop comprised of a positive limb of basic helix-loop-helix (bHLH) transcription factors brain and muscle Arnt-like protein (Bmal)1, circadian locomotor output cycles kaput (Clock), and neuronal PAS domain-containing protein (Npas)2 and a negative limb of regulatory proteins period (Per)1, -2, and -3 and cryptochrome (Cry)1 and -2. 8 Heterodimers of Bmal1 with Clock or Npas2 act as activators and drive transcription through E-boxes located within the promoters of Per and Cry genes. Posttranslational modifications regulate Per and Cry proteins, which then feedback and inhibit the positive limb, resulting in rhythmic oscillation of clock components. At the same time, additional feedback loops participate in the core of the circadian clock. Bmal1, Clock/Npas2 heterodimers drive the transcription of the nuclear receptors Rev-Erb␣ and RORE␣ (retinoic acid-related orphan receptor element ␣), which in turn repress or activate Bmal1 transcription, respectively. The positive limb of the oscillator regulates not only the transcription of clock components but also a significant percentage of the transcriptome, imposing a rhythm in cellular physiology by creating a rhythm in gene expression. 9 The oscillator exists in every cell and tissue examined with the exception of the testis. 8, 10 The circadian system is largely organized in a hierarchical manner. Surgical ablation of the suprachiasmatic nucleus (SCN) in the hypothalamus ablates all hormonal and activity rhythms, suggesting the existence of a master circadian pacemaker located in the SCN. 11 Circadian clocks have been described in many different peripheral tissues, and evidence for the tissue-specific role of the oscillator is beginning to accumulate. In this review, we describe aspects of vascular physiology that display circadian rhythms and provide the evidence that support a role for the circadian clock in the regulation of vascular function.
Vascular Function Exhibits Diurnal Rhythmicity
The existence of a circadian rhythm in the function of human blood vessels has long been recognized. 12 Two aspects of vascular function, vascular tone and thrombus formation, have been studied in respect to the daily cycle. We have previously described a circadian variability in both sympathetic tone and vascular reactivity to adrenergic receptor agonists. 13 Other studies have shown that vascular tone exhibits a circadian variation in humans. 14 Blood flow and vascular resistance in the forearm and the vasodilator response to phentolamine (an ␣-adrenergic-antagonist) but not to sodium nitroprusside (a direct vasodilator) varies at different times of the day. 14 Flow-mediated dilation of brachial artery, a widely used clinical index of endothelial function, displays diurnal variation when examined in healthy young men. 15 The sensitivity of aortic preparations to either vasoconstrictor or vasorelaxing agents is different at different times of the daily cycle, with both endothelium-dependent and -independent relaxations being more pronounced at 3:00 AM than at other times of the day. 16 In support of the latter, endothelial NO synthase (eNOS) activity exhibits circadian variation, possibly as a result of a variation in its state of phosphorylation. [17] [18] [19] [20] Platelet aggregation and the thrombus formation subsequent to plaque rupture may precipitate vascular occlusion and resultant tissue infarction and ischemia. Although there have been reports of diurnal variation in platelet aggregability ex vivo, 21 the relationship of these observations (prone as they are to artifact ex vivo, attributable in part to diurnal variation in extracellular fluid volume in vivo) to actual platelet activation in vivo is unknown. However, factors external to the platelet (such as plasminogen activator inhibitor [PAI]-1 and tissue plasminogen activator (tPA), which are produced by the vascular endothelium and do indeed oscillate) may influence platelet activation in vivo. PAI-1 and tPA are produced by the vascular endothelium and show diurnal variability throughout the day/night cycle. Other mediators of the hemostatic system display diurnal variation, including coagulation factors (II, VII, X, and tissue factor pathology inhibitor [TFPI]). [22] [23] [24] Fibrinogen, the circulating precursor of fibrin (a clot-stabilizing protein), displays circadian variation in humans, 25 with a peak in the early morning. We recently showed that the time to thrombotic vascular occlusion in response to a photochemical injury displays diurnal variation. 26 
A Functional Circadian Clock Exists Within Different Cellular Elements of the Vasculature
The first molecular evidence of the existence of a circadian clock in the vasculature came with the identification of rhythmic oscillation in gene expression of clock components in mouse aortas isolated at different times throughout the 24-hour period. [27] [28] [29] [30] 32, 33 The rhythmic pattern of expression persists for more than 20 days in culture, suggesting the existence of self-sustained circadian clocks in fibroblasts. 34 Dramatic oscillations in circadian clock components have been observed in vascular SMCs (VSMCs) throughout the 24-hour period. 27, 28, 35 Synchronization of hemangioendothelioma cells in culture with serum resulted in circadian expression of clock genes, providing evidence for the existence of a circadian clock in vascular endothelial cells. 36 Although we identified rhythmic expression of Bmal2 and Per2 in VSMCs in culture following serum shock, 27 we failed to detect rhythmic oscillations of clock components in endothelial cells isolated from aorta after serum shock. 26 The oscillations in Per1/2, Cry1/2 mRNA levels in the mouse aorta peak during early circadian night (the time period during constant darkness that corresponds to the night period of a regular day/night cycle), whereas Bmal1 and Npas2 peak at the beginning of circadian day (the time period under constant darkness corresponding to the day period of a regular day/night cycle). These findings indicate that the circadian oscillator in aorta is in temporal phase alignment with the master circadian oscillator in the SCN in mice. Cultures of vascular VSMCs also show an inverse phase among Per, Cry, and Bmal1 gene expression ( Figure 1 ). It is still unknown whether individual cells in the vasculature communicate timing information to each other. Single-cell recordings and coculture experiments indicate that cultured fibroblasts do not influence each other's rhythms to any measurable degree. 33 However, different tissue explants harvested from the same SCN-lesioned animal display circadian oscillations with different phases and period lengths. 34 This suggests that intercellular communication within an organ may exist. Further evidence of intercellular communication of timing information comes from the intercellular coupling of SCN neurons that is essential for synchronization and robustness of cellular oscillators. 37 As we already mentioned, the circadian oscillator of the aorta is in temporal phase alignment with the SCN, suggesting that as with the other peripheral oscillators, the SCN provides synchronizing cues to the circadian clock of the vasculature. However, the oscillator of the vasculature responds to signals other than the ones coming from the SCN. These signals may entrain the oscillators in the vasculature out of phase with the SCN. We have shown previously that retinoic acid and the synthetic glucocorticoid dexamethasone phase shift Per2 mRNA rhythms in human vascular SMCs. 27 Our findings suggest that periodic availability in steroid hormones and vitamins, such as retinoids, might phase shift or reset the peripheral clocks of cells in the vasculature.
Vascular Clock Output
The circadian oscillator of any cell regulates the expression of a number of genes (called circadian clock output genes), resulting in rhythms in physiological processes. It is quite possible that molecular clocks within the different cell types of a vessel may express different circadian output genes. According to several microarray studies, 38 -40 clock output genes vary widely between different cell types in different tissues, suggesting a tissue-specific role of clocks. This is consistent with the possibility that the genes under circadian control may differ between the different cells types of the vascular bed.
We examined the rhythmic expression of genes in the thoracic aorta using high density arrays. 40 Genes relevant to protein folding, protein degradation, glucose and lipid metabolism, adipocyte maturation, vascular integrity, and the response to injury demonstrated a circadian pattern of oscillation in mouse aorta. The number of genes exhibiting circadian expression (307 genes of Ϸ8000 probe sets examined) corresponds to the 5% to 10% of the transcriptome reported to oscillate in other tissues. The genes with an oscillating pattern of expression in aorta provide a list of candidate genes under the control of the vascular clock. Studies in vascular In the mouse aorta, clock gene mRNA transcripts Per2, Bmal1, and Clock output gene dbp display circadian oscillations. Clock and Bmal1 heterodimers drive transcription of Per2 and dbp by binding to E-box consensus sequences in their promoters. The peak in Per2 and dbp expression is observed around circadian time (CT)36 corresponding to the transition between the light and dark period. Bmal1 expression is driven by ROR␣ (retinoic acid-related orphan receptor ␣) acting at Rev response element (RRE) sequences and subsequently repressed by RevErb␣. The peak in Bmal1 expression is observed at CT24 corresponding to the transition from the dark phase to the light phase. Mouse aortas were harvested in constant darkness. Clock gene mRNA transcripts similarly display circadian rhythmicity in human and mouse aortic SMCs after treatment with 50% serum. The phase of the rhythms of these cells cultured in vitro is expected to be different from the in vivo rhythm because of the effect of the autonomous nervous system. Oscillation of the clock output gene dbp in SMCs is in phase with Per2 with a peak at tϭ24 hours after serum shock in human cells. Per2 and dbp peak slightly earlier (close to tϭ18 hours) in mouse SMCs. Expression of Per2, Bmal1, and dbp was monitored by quantitative PCR. Reproduced from Reilly et al 35 with permission.
endothelial cells have identified Pai-1 and thrombomodulin as targets of the circadian clock of the vascular endothelium. 36, 41, 42 The Pai-1 gene contains 2 consensus E-boxes in its promoter and is driven by the endothelial-specific circadian heterodimer Bmal2:Clock 42 and also Bmal1:Clock. 41 The Bmal2:Clock heterodimer binds directly to the E-box of the thrombomodulin promoter and drives its rhythmic expression in vascular endothelial cells. 36 The above findings suggest a role of the vascular clock in a variety of vascular functions including pressor responses and thrombogenesis.
Evidence for the Importance of Circadian Clocks in Vascular Function
The evidence to support a role of the circadian clock in vascular function comes primarily from animal models with genetic deletion of components of the circadian clock. The sensitivity of aorta to vasoactive agents is described to vary according to time of day. 16 This variation is altered in mice with mutated circadian clock elements, whereas the downstream effector response to NO, through guanylyl cyclase, remains intact. 17, 43 The latter is consistent with observations in humans demonstrating that the response to sodium nitroprusside does not vary according to time of day. 14 In individuals with compromised endothelial function, this diurnal variation in vascular endothelium-dependent vasodilatation is blunted. 44 Endothelium-dependent relaxations are reduced in Per2 mutant mice, and the diurnal variation that the relaxations normally exhibit is absent in the mutant mice. Aortic rings isolated from Per2 mutant mice exhibit impaired endothelium-dependent relaxations to acetylcholine, 43 which stimulates NO release from the endothelium via activation of endothelial acetylcholine-M 3 receptor. 45 The expression of endothelial acetylcholine-M 3 receptor or eNOS is not altered in the aortas of Per2 mutant mice. Moreover, the endothelium-dependent relaxations to ionomycin, which stimulates eNOS enzymatic activity via nonreceptor-mediated increase in intracellular Ca 2ϩ concentration, are also reduced significantly in the Per2 mutant mice during the inactive phase of the daily cycle. This reduced response to ionomycin is improved by the cyclooxygenase (COX) inhibitor indomethacin, suggesting an increase in COX-derived vasoconstrictors in the Per2 mutants. Aortas from Per2 mutant mice express significantly higher COX-1, and indomethacin is able to abolish the differences in endothelium-dependent responses to ATP described in aortic rings from Per2 mutant mice. 43 Recent data are also consistent with impaired eNOS signaling and endothelial function in mice with dysfunctional circadian clocks. 17, 19 eNOS expression is not modified in these mice, but there is evidence that post-translational mechanisms regulating eNOS activity are compromised, consistent with observations demonstrating that eNOS activity exhibits a circadian variation, 20 which may be a consequence of its phosphorylation state. [17] [18] [19] Changes in catecholamine production in mice with dysfunctional circadian oscillators may also contribute to the abnormal vasoactive responses described in these mice. Bmal1 knockout and Npas2 mutant mice 46 and endothelial cell-specific peroxisome proliferator-activated receptor (PPAR)␥ knockout mice, which have reduced Bmal1, 47 all have substantially reduced levels of norepinephrine and epinephrine in plasma, both at night and during the day. The catecholamine-mediated vasoconstriction response to an ␣ 1 -adrenergic receptor agonist is suppressed in Cry-deficient mice. 48 This suppression of the ␣-adrenoceptor response may be caused by an impaired intracellular pathway for ␣-adrenoceptor-mediated contraction of vascular SMCs, including reduced expression of ␣-adrenoceptors. This result is consistent with the possibility that Cry genes in the vasculature contribute to circadian changes in arterial blood pressure regulation by modulating ␣-adrenoceptor-mediated vasoconstriction in the peripheral vessels. However, it is possible that dysregulation of the clock in the vasculature results from a depletion of sympathetic nervous input after disruption of the central circadian clock in the Cry knockout mice.
The impaired vascular responses in mice with dysfunctional clocks are reflected in the blood pressure of these mice. Transgenic mouse models with disrupted circadian clocks exhibit alterations in blood pressure and its variability over time. 46, 48 Bmal1 knockout mice have reduced mean arterial pressure especially during the active phase of the day. 46 Bmal1 deletion alters the expression of catechol-O-methyl transferase (Comt) in aorta, an enzyme that accounts for an extraneuronal low-affinity high-capacity "sink" for clearance of catecholamines. 46 Comt participates in the regulation of blood pressure, with Comt-deficient mice being resistant to salt induced hypertension. 49 Kininogen, another gene of potential relevance to blood pressure control, 50 was also dysregulated in the aorta of Bmal1 knockout mice. 46 Similar to the universal Bmal1 knockout mouse, deletion of Bmal1 specifically in vascular endothelium leads to a reduction of blood pressure during the active phase of the day and increased heart rate throughout the 24-hour cycle without changes in plasma catecholamines, NO biosynthesis, or fibrinolytic efficiency. 26 In agreement with the findings from Bmal1 deletion, Npas2 mutant mice 46 and Per2 mutant mice 43 had reduced mean arterial pressure, irrespective of clock time. On the other hand, the circadian variation in blood pressure was lost in Cry1/Cry2 double knockout mice 48 and Clock mutants, 46 without changes in overall pressure levels. In addition to those models of disrupted clock function, deletion of PPAR␥ in vascular endothelial and SMCs resulted in a reduction of Bmal1 expression and blunting of the diurnal variation of blood pressure. 47 The endothelial cellspecific deletion of PPAR␥ led to a reduction in blood pressure only during the active phase similar to the reduction described in the endothelial-specific knockout of Bmal1. Interestingly, the SMC-specific deletion of PPAR␥ resulted in an increase of the blood pressure during the resting phase with no change during the active phase. 47 The endothelial dysfunction observed in mice with dysfunctional clocks may reflect increased vascular senescence. 19 The ability of endothelial cells from Per2 mutant mice to proliferate and form vascular networks is substantially reduced. 19 Reduced proliferative capacity is a marker of increased senescence of endothelial cells. Moreover, aortas and endothelial cells isolated from Per2 mutant mice show increased senescence as assessed by ␤-galactosidase activity, accompanied by increased Akt signaling. Inhibition of Akt signaling restored the impaired vascular network formation and endothelial cell proliferation in Per2 mutant mice. On the other hand, overactivity of Akt has been linked to increased vascular senescence through increased reactive oxygen species generation and decreased NO bioavailability, as well as impaired angiogenesis. 51, 52 Per2 mutant mice show decreased angiogenesis in 2 different in vivo experimental models. Incorporation of hemoglobin, which correlates with vessel formation, after subcutaneous implantation of matrigel is reduced in Per2 mutant mice compared to wild-type mice. 19 In a second model, Per2 mutants show autoamputation and impaired blood flow recovery in response to ischemia characterized by a smaller increase in endothelial progenitor cells. 19 Bone marrow transplantation experiments showed reduced blood flow recovery to ischemia in mice receiving bone marrow from Per2 mutants, suggesting a role of bone marrow derived endothelial progenitor cells in ischemiainduced neovascularization. 19 However, blood flow recovery in Per2 mutant mice receiving bone marrow from wild-type mice was only partially restored to wild-type levels, suggesting that impaired intrinsic vascular function, in addition to impaired endothelial progenitor cells function, contributes to the altered angiogenic response and autoamputation in Per2 mutants. In support of a role for endothelial progenitor cells in ischemia-induced neovascularization, infusion of wild-type endothelial progenitor cells in Per2 mutant mice restores ischemia-induced neovascularization and blood flow recovery. It is known that circadian rhythms affect stem cell function; thus, disruption of circadian genes is likely to affect the function of bone marrow-derived cells, including endothelial progenitor cells. 53, 54 Both increased endothelial senescence and decreased endothelial progenitor cell mobilization may contribute to the autoamputation observed in Per2 mutant mice.
Recently, we showed that deletion of Bmal1 specifically in the vascular endothelium results in loss of the temporal pattern in susceptibility to thrombotic vascular occlusion, as assessed by a vessel injury model. 26 The diurnal variation in the time to thrombotic vascular occlusion in response to photochemical injury was also completely abolished in Clock mutant mice, further supporting a role of the circadian clock. 26 The deletion or mutation of clock components not only abolished the diurnal variation in thrombogenesis but also had an impact on the functional response of the endothelium. The time to thrombotic vascular occlusion (TTVO) was shorter in mice with endothelial deletion of Bmal1. A shorter TTVO was also observed in global Bmal1 knockout mice. The observed difference in TTVO does not appear to be attributable to alterations in arterial blood flow because overall baseline blood flow was not altered in mice with both global and endothelial-specific deletion of Bmal1. On the other hand, Clock mutant and Npas2 knockout mice had a significantly longer time to thrombotic vascular occlusion. The difference among Clock mutant, Npas2 knockout mice, and mice with endothelial-specific deletion of Bmal1 in TTVO may be attributed to the lower plasma PAI-1 levels in Clock mutant and Npas2 knockout mice. Mice with endothelial-specific deletion of Bmal1 have normal PAI-1 and tPA plasma levels. 26 The role of the circadian clock in vascular function was recently investigated in a model of blood flow reduction. Arteries of young Bmal1 knockout mice were unable to adapt to chronic reduction of blood flow by inward luminal remodeling. 17 This response of the arteries of Bmal1 knockout mice was accompanied by a substantial increase in collagen deposition in the medial layer and increased thickening of the arterial wall. Older Bmal1 knockout mice exhibited a significant susceptibility to thrombosis in response to vessel ligation. The thrombosis was accompanied by tissue remodeling around the site of thrombus formation. In arterial regions that were thrombus-free, aged Bmal1 knockout mice revealed a paradoxical enlargement of lumen diameter after ligation. 17 Both Clock mutant and Bmal1 knockout mice exhibited a significant increase in neointimal area and intima to medial ratio in response to mechanical injury of the vascular endothelium under constant darkness. 17 However, under a regular light/dark daily cycle, the wall thickening and inward remodeling induced by arterial ligation were not different between wild-type and Clock mutant mice, providing strong evidence for a direct link between light cycle-and circadian rhythmdependent changes in vascular function. Moreover, PAI-1 was upregulated in the remodeled vascular endothelium of Bmal1 knockout mice. Aortas from both Bmal1 knockout and Clock mutant mice exhibited a severely impaired vasorelaxant response to acetylcholine relative to wild-type mice under constant darkness. This impaired response in Clock mutant mice was again not apparent under light/dark conditions, providing further evidence in support of a direct link between the biological clock and vascular integrity. The impairment in aortic relaxation in Bmal1 knockout mice was improved by administration of the superoxide oxygen radical scavenger superoxide dismutase, without changes in the SMC responses to NO. The endothelial dysfunction and pathological vascular remodeling observed in Bmal1 knockout mice was attributed to reduced Akt signaling. In addition, attenuation of phosphorylated eNOS (a target for Akt to exert its regulatory role in vascular function) was also described in the arteries of Bmal1 knockout mice. The effects of circadian clocks in the regulation of vascular function are summarized in Figure 2 . The Table provides a summary of the vascular phenotypes observed in genetic models of dysfunctional clocks.
The only study not using genetic deletion of clock components to investigate the effect of the disruption of the circadian clock on vascular function was performed in a mouse model of cardiac hypertrophy. Disruption of the circadian clock by altering the light cycle to a 10-hour light/10-hour dark phase scheme resulted in abnormal thinning as opposed to hyperplasia of the aorta vessel wall and less hypertrophy of vascular muscle cells. 55 
Circadian Clocks Residing Outside the Vasculature and Vascular Function
In all of the previous studies, with the exception of that involving mice with endothelial deletion of Bmal1, it is unclear whether the effect on the vasculature comes from a circadian oscillator residing inside or outside the vasculature. Although our study on the deletion of endothelial Bmal1 strongly suggests a role of the vascular clock in the physiology of the vasculature, we may not exclude a role for ectopic circadian oscillators. Several lines of evidence indicate the participation of the master oscillator in the SCN and other peripheral oscillators in the production and circadian variation of potent vasoactive proteins. The SCN impinges on the circadian rhythm in glucocorticoid release by regulating both the hypothalamic-pituitary-adrenal axis and the autonomic nervous system. 56, 57 Recently, a SCN-dependent lightinduced release of corticosterone in the adrenal gland has been described without an accompanying activation of the hypothalamo-adenohypophysial axis. This highlights the importance of the circadian clock in the phenomenon. 58 Glucocorticoids, of which cortisol in humans 59 and corticosterone in rodents 60 are the most potent, have robust diurnal rhythms. Glucocorticoids can suppress the induced production of vasodilators, such as prostacyclin and NO in the endothelium. 61 The arterial contractile sensitivity to catecholamines is potentiated by glucocorticoids. Glucocorticoids are also known to suppress inflammation and regulate vascular permeability through control on tight junction proteins. 61 Another set of vascular effectors regulated by the circadian clock is the catecholamines epinephrine and norepinephrine. Catecholamines are potent vasoactive hormones that contribute acutely to vasoconstriction, endothelial dysfunction and platelet activation. Both epinephrine and norepinephrine oscillate with a diurnal rhythm. 62 Amplification of the diurnal variation of catecholamines may influence atherogenesis and the response to vascular injury. 63 Animal models suggest that the positive components of the molecular clock can affect expression of key rate-limiting enzymes in catecholamine generation such as tyrosine hydroxylase, 64 Comt, phenylethanolamine-N-methyl transferase (Pnmt), and monoamine oxidase (mao)B. 46 Interestingly, catecholamines are potent synchronizers of the circadian clock, raising the possibility that their effect on vascular function is mediated, at least in part, through the vascular clock. Depletion of both norepinephrine and epinephrine, by genetic deletion of dopamine ␤-hydroxylase, results in loss of the diurnal oscillation in blood pressure. 35 Norepinephrine and epinephrine acting via ␣ 1 -and ␤ 2 -adrenergic receptors phase shift the circadian clock in mouse and human vascular SMCs in vitro. 35 However, aortic clocks in dopamine ␤-hydroxylase knockout mice that cannot synthesize either norepinephrine or epinephrine can be entrained by food restriction. 35 Similar to catecholamines, we found glucocorticoids to be potent synchronizers of the circadian oscillator in the VSMCs. 27 A third potent synchronizer of the oscillator in VSMCs is angiotensin II. Angiotensin II exhibits considerable diurnal variation and plays a central role in the regulation of systemic blood pressure through multiple effects, some of which are exerted on the vasculature. 65, 66 Treatment of VSMCs with angiotensin II induces significant oscillation in bmal1, per2, and D-element-binding protein (dbp). 28 Overexpression of the renin II gene in the rat is associated with a phase delayed or inverted circadian rhythm of blood pressure, attenuated circadian and photic induction of c-fos gene in SCN neurons, and attenuated phase shifting of behavioral and cardiovascular rhythms in response to light. 67, 68 Studies in angiotensin II type 2 receptor knockout mice reveal disrupted circadian rhythms in blood pressure and heart rate compared with wild type mice. 69 All of the above findings raise the possibility that glucocorticoids, catecholamines, and angiotensin II may contribute to regulation of vascular function including integration of the SCN with the peripheral oscillators in the vasculature (Figure 3 ). In support of this, a recent study of the clockdeficient Cry1/Cry2 double knockout mouse showed saltsensitive hypertension as a result of increased aldosterone production by the adrenal gland. 70 
Conclusion
Although diurnal variation in vascular physiology has been long recognized, many aspects of how the molecular clock influences vascular function remain unknown. During the past decade, a model of function for the circadian clock has been developed. Disruption of this model by genetic manipulation suggests an influence of the molecular clock on diverse aspects of cardiovascular function. However, it is known that many of the circadian clock genes have nonclock-related actions; therefore, careful interpretation of those studies is needed. Future use of tissue-specific knockout models of circadian clock components and the use of diversified models of clock dysfunction will hopefully prove helpful in unraveling the network of circadian oscillators residing both inside and outside the vasculature that regulate cardiovascular biology. Understanding the role of the clock in vascular function should eventually lead to mechanistic explanations of the temporal incidence in adverse cardiovascular events and present novel therapeutic opportunities. One of the major challenges in this effort will be the identification of mechanisms underlying the oscillations in vascular physiology. This knowledge will potentially enable prospective studies of therapies targeting vascular pathology in respect to diurnal variation. Furthermore, therapeutic approaches may be designed to act in an anticipatory way. Already, antihypertensive drug therapy is timed to intercept the morning surge in blood pressure and has been developed with diurnal variation in drug metabolism in mind. However, the ultimate goal is to identify and target for correction the fundamental defects leading to dysregulated rhythms of vascular physiology.
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